Addex Therapeutics ADXN
NASDAQ ADXN
$2.98 +0.22 (+7.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Other Non-Current Assets (2020 - 2025)

Updated

Addex Therapeutics (ADXN) posted Other Non-Current Assets of $72,563 for Q2 2025.

Analysis

Addex Therapeutics (ADXN) Other Non-Current Assets (2020 - 2025) Analysis & Trends

At the end of FY2024, Addex Therapeutics' Other Non-Current Assets came in at $9,056.

  • Annual Other Non-Current Assets shows a four-year compound annual growth rate of -52.6% (FY2020 to FY2024).
  • In prior years, Addex Therapeutics' Other Non-Current Assets was $180,125 in FY2020.
  • The Q2 2025 figure stands as the highest quarterly Other Non-Current Assets since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Addex Therapeutics 2.47 Mn 2.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 72,562.80
Dec 31, 2024 9,094.50
Dec 31, 2020 180,125.27
API Access

Addex Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ADXN&period=max&api_key=YOUR_API_KEY